ConductScience.org, home

Paper29045232

Imaging Neoadjuvant Therapy Response in Breast Cancer.

Fowler AM and 2 others. Radiology, 2017. Cited by 189 papers, by iCite.

Cite this record

ConductScience Library. Imaging Neoadjuvant Therapy Response in Breast Cancer. Papers, record 29045232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29045232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Imaging Neoadjuvant Therapy Response in Breast Cancer.
PubMed
Journal
Radiology
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
189
iCite
Relative citation ratio, by iCite
7.06
iCite
Revised in PubMed
2018-04-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fowler AMAmy M
2Mankoff DADavid A
3Joe BNBonnie N

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BreastMajor topic
Breast NeoplasmsMajor topic
Magnetic Resonance ImagingMajor topic
Molecular ImagingMajor topic
Positron Emission Tomography Computed TomographyMajor topic
Aged
Contrast Media
Female
Humans
Middle Aged
Neoadjuvant Therapy

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05951699Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary ChemotherapyResults

Source ClinicalTrials.gov

Download CSV of trials

Cited by133

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 189 citations.

PMIDTitleJournalYearIn PapersSource
42807117Modelling image quality over extended [18F]FDG uptake times for low-dose positron emission mammography.Front Oncol2026https://conductscience.org/library/papers/42807117PubMed
42699276Performance of MRI-based deep learning models in differentiation of triple negative breast cancer from other breast cancer subtypes: A systematic review and meta-analysis.Eur J Radiol Open2026https://conductscience.org/library/papers/42699276PubMed
42661023On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort.Br J Cancer2026https://conductscience.org/library/papers/42661023PubMed
4256261068Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study.J Nucl Med2026https://conductscience.org/library/papers/42562610PubMed
42421849Gramado consensus on imaging evaluation of the response to neoadjuvant systemic therapy for breast cancer.Radiol Bras2026https://conductscience.org/library/papers/42421849PubMed
42358985Early identification of neoadjuvant therapy non-response via multimodal immune-imaging biomarkers in breast cancer.Front Immunol2026https://conductscience.org/library/papers/42358985PubMed
42211537The Neoadjuvant Approach to Treatment of Breast Cancer: Multidisciplinary Management to Improve Outcomes.Surg Oncol Insight2024https://conductscience.org/library/papers/42211537PubMed
42194721Baseline and Early-Delta Quantitative Ultrasound Radiomics for Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.J Clin Med2026https://conductscience.org/library/papers/42194721PubMed
42137125Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients.Gastroenterol Hepatol Bed Bench2025https://conductscience.org/library/papers/42137125PubMed
41972087Optimizing abbreviated breast MRI protocols for the early assessment of neoadjuvant chemotherapy response in breast cancer.Quant Imaging Med Surg2026https://conductscience.org/library/papers/41972087PubMed
41695376Early peritumoral edema change improve prediction of pathological complete response in breast cancer: a multiparametric magnetic resonance imaging-based model.Front Oncol2026https://conductscience.org/library/papers/41695376PubMed
41576341Identification and Localization of Breast Tumor Components via a Convolutional Neural Network Based on High-Frequency Ultrasound Combined With Histopathologic Registration: Prospective Study.JMIR Med Inform2026https://conductscience.org/library/papers/41576341PubMed
41543378From Voxel-wise Fitting to Generative Translation: A Path for Quantitative DCE MRI Analysis in Breast Cancer.Radiol Imaging Cancer2026https://conductscience.org/library/papers/41543378PubMed
41536974Dual-input spatio-temporal transformer model: Predicting the efficacy of NACT in breast cancer based on DCE-MRI images.iScience2026https://conductscience.org/library/papers/41536974PubMed
41352211Emerging technologies for monitoring breast cancer response to neoadjuvant chemotherapy: a systematic scoping review.Breast2026https://conductscience.org/library/papers/41352211PubMed
41333210
Assessment of the efficacy of various neoadjuvant anti-HER2 targeted therapies combined with chemotherapy for HER2-positive breast cancer in the real-world setting and development of a predictive model for pathological complete response.
Front Oncol2025https://conductscience.org/library/papers/41333210PubMed
41301040The Role of Quantitative Ultrasound in Monitoring Neoadjuvant Chemotherapy in Breast Cancer: A Narrative Review.Cancers (Basel)2025https://conductscience.org/library/papers/41301040PubMed
41104977Elastography and MRI for the Evaluation of Complete Response to Neoadjuvant Therapy for Breast Cancer.Radiol Imaging Cancer2025https://conductscience.org/library/papers/41104977PubMed
40977301Early prediction of neoadjuvant chemotherapy efficacy among patients with triple-negative breast cancer using an ultrasound-based radiomics nomogram.Diagn Interv Radiol2025https://conductscience.org/library/papers/40977301PubMed
40775094Can we cut the contrast? DWI shows similar value to standard MRI for assessing treatment response in breast cancer.Eur Radiol2025https://conductscience.org/library/papers/40775094PubMed

See all 133 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29045232

GET https://conductscience.org/api/papers/v1/29045232/cited_by?page=2